-
THAP11 mutations in a patient with a cblX-like phenotype implicates THAP11 in the regulation of cobalamin metabolism and early vertebrate development
Study
EGAS00001002201
-
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
Study
EGAS00001004212
-
European BestAgeing Study on microRNA candidates for cardiovascular disease
Study
EGAS00001008346
-
Tracking the evolution of Therapy-Related Myeloid Neoplasms using chemotherapy signatures
Study
EGAS00001006903
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Whole-genome Sequencing Suggests Mechanisms for 22q11.2 deletion-associated Parkinson’s disease
Study
EGAS00001002275
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Whole genome sequencing of tumor samples from advanced pre-treated NSCLC patients recruited in a phase I/II single-arm trial utilising CVA21, an oncolytic coxsackie virus, in combination with pembrolizumab.
Study
EGAS00001008258
-
Sequencing of paediatric High Grade Gliomas and DIPG
Study
EGAS00001002314
-
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down Syndrome
Study
EGAS00001002410
-
Genomic diversity of the African-descent Makranis of Pakistan
Study
EGAS00001002558
-
Ultra-Fast Patient-Derived Xenografts Identify Functional and Spatial Tumour Heterogeneities that Drive Therapeutic Resistance
Study
EGAS00001002627
-
The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results from a multicenter study
Study
EGAS00001002894
-
Exploiting immune cell receptor information to quantify index switching in single cell transcriptome sequencing experiment
Study
EGAS00001002911
-
A genome scan for genes underlying adult body size differences between Central African hunter-gatherers and farmers.
Study
EGAS00001002975
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Genomic landscape of oral cancers (Complete Genomics WGS)
Study
EGAS00001002393
-
Indonesian Genome Diversity Project
Study
EGAS00001003054
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064
-
Exome sequencing in bipolar disorder families
Study
EGAS00001003085
-
Resolving the Full Spectrum of Human Genome Variation using Linked-Reads
Study
EGAS00001003121
-
RNA seq on 19 samples of Radiation-Induced Meningiomas
Study
EGAS00001002318
-
1 Intratumoral genetic heterogeneity and clonal evolution following neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal tumors.
Study
EGAS00001003250
-
Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001003258
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - WXS
Study
EGAS00001003275
-
Genomic landscape of oral cancers (Illumina RNA-Seq)
Study
EGAS00001003237
-
The Immune Microenvironment, Genome–Wide Copy Number Aberrations and Survival in Mesothelioma
Study
EGAS00001002323
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease
Study
EGAS00001003071
-
Comparison of capture-based method for transcriptome profiling of formalin-fixed paraffin embedded tumor samples
Study
EGAS00001005255
-
Are children born after medical assisted reproduction at greater risk of having an increased de novo mutation rate?
Study
EGAS00001005569
-
Targeted Gene Panel for 171 PTCLs
Study
EGAS00001002740
-
The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective longitudinal and ethnically diverse cohort
Study
EGAS00001008040
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
RNA-seq as a tool for evaluating human embryo competence
Study
EGAS00001003667
-
Altered oligodendrocyte heterogeneity in Multiple sclerosis revealed by single nuclei RNA sequencing
Study
EGAS00001003412
-
A molecular cell atlas of the human lung from single cell RNA sequencing
Study
EGAS00001004344
-
We evaluate the potential for routine WGS using ONT by sequencing the well-characterised reference sample NA12878 and the genome of an individual with ataxia-pancytopenia syndrome accompanied by severe immune dysregulation.
Study
EGAS00001003469
-
Persistence of circulating tumor DNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumor response
Study
EGAS00001005798
-
Post_Mortem_Tissue_COVID19_RNA
Study
EGAS00001004442
-
A reference map of potential determinants for the human serum metabolome
Study
EGAS00001004512
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Mutational Landscape and Tumor Burden Assessed by Cell-Free DNA in Diffuse Large B-Cell Lymphoma: a Population-based Study
Study
EGAS00001004733
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
18 Whole Exome Sequencing for Radiation Induced-Meningiomas
Study
EGAS00001002317
-
Breast cancer women lack normal lifelong immune response after full-term pregnancies
Study
EGAS00001002616
-
DSRCT RNA genomic sequencing
Study
EGAS00001002770
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Genetic diversity and continuity of the population of the UAE
Study
EGAS00001004362
-
Matching of actionable mutations with therapies in cancer patients: comparison of three commercial decision support platforms
Study
EGAS00001004383
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Post_Mortem_Tissue_COVID19_spatial
Study
EGAS00001004441
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
An analysis of humoral and cellular immune responses following COVID-19 vaccination.
Study
EGAS00001005380
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
IMCISION DNAseq
Study
EGAS00001005466
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Genetics and therapeutic responses to TIL therapy of pancreatic cancer PDX models
Study
EGAS00001005596
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Monocyte and macrophage lipid accumulation results in downregulated type-I interferon responses
Study
EGAS00001005955
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Profiling the unique protective properties of intracranial arterial endothelial cells
Study
EGAS00001004479
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Stromal-induced epithelial-mesenchymal transition induces drug resistance in acute lymphoblastic leukemia
Study
EGAS00001006120
-
Exploration of coding and non-coding variants in cancer using GenomePaint.
Study
EGAS00001004669
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
Study
EGAS00001005863
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
Combination of CDK4/6 with BET-bromodomain and PI3K/mTOR inhibitors in medulloblastoma in vitro and in vivo
Study
EGAS00001006286
-
Long-term temporal stability of peripheral blood DNA methylation alterations in patients with inflammatory bowel disease.
Study
EGAS00001006501
-
BCR Signaling in human BM PC
Study
EGAS00001004948
-
Immune microenvironment and lineage tracing help deciphering Rosette-forming GlioNeuronal Tumors: a multi-omic analysis of 9 cases
Study
EGAS00001006502
-
Exome sequencing from cfDNA blood samples. 159 samples at 2x101bp Illumina reads in Fastq format.
Study
EGAS00001006656
-
Single_cell_measurements_to_characterise_B_cell_repopulation_in_SLE_after_rituximab_therapy__a_pilot_study
Study
EGAS00001006798
-
Analysis of T-cell receptor clonotypes in tumor micro-environment identifies shared cancer type-specific signatures
Study
EGAS00001005480
-
T-cell receptor sequencing of tumor-infiltrating lymphocytes (TIL) in breast cancer
Study
EGAS00001007125
-
IL7-receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK-inhibition
Study
EGAS00001007144
-
cfDNA dataset from the urine supernatant of ovarian cancer patients and healthy controls
Study
EGAS00001007238
-
Whole genome sequencing of 108 epileptic patients from CENet cohort
Study
EGAS00001007507
-
Copy numbers in resectable gastric cancer treated with surgery alone
Study
EGAS00001007394
-
Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer
Study
EGAS00001007396
-
Regenerative effects of MSC treatment on busulfan-induced small intestine damaged organoids.
Study
EGAS00001007432
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Dynamics of circulating tumor DNA in acute myeloid leukemia (AML) patients who undergo allogeneic transplantation
Study
EGAS00001007969
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Influence of age on molecular changes and treatment stratification in multimodal glioblastoma therapy
Study
EGAS00001008246
-
Next Generation Children project
Dataset
EGAD00001007868
-
EPICC: Evolutionary Predictions in Colorectal Cancer WGS-3
Dataset
EGAD00001008642
-
Clonal dynamics after allogeneic haematopoietic cell transplantation using genome-wide somatic mutations - WGS
Dataset
EGAD00001010872
-
Single cell RNA sequencing of synovial B cells in early Rheumatoid Arthritis
Dataset
EGAD00001009076
-
A catalog of the genetic causes of Hereditary Angioedema in the Canary Islands (Spain)
Study
EGAS00001006547
-
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Study
EGAS00001007242
-
H3Africa - Genomic Characterization and Surveillance of Microbial Threats in West Africa
Study
EGAS00001007250
-
Tubulointerstitial fibrosis is the histological hallmark of chronic kidney disease (CKD). Hypoxia and inflammation (i.e., interleukin (IL)-1β signalling) are independent mediators of tubulointerstitial fibrosis. However, the physiological response of human kidney tubular cells to IL-1β/IL-1RI signalling under the hypoxic conditions of CKD is poorly understood and remains a clinical imperative for therapeutic targeting. This study reports that hypoxia and IL-1β act in synergy to trigger cell cycle arrest/cellular senescence of ex vivo patient-derived primary proximal tubular epithelial cells (PTECs).
Study
EGAS00001007904
-
Identification of intronic sequences promoting natural skipping of ABCA4 exon 15 using long-read transcriptomics and midigene assays
Study
EGAS50000000071
-
Blueprint Data Access Committee.
Dac
EGAC00001000135
-
Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial
Study
EGAS50000000470
-
Genomic Profiling of Pediatric Tumors by Cell Free DNA Sequencing
Study
EGAS50000000072
-
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Study
EGAS50000000809
-
A prospective study identifies MisMatch Repair genes as candidate predisposing genes for uveal melanoma.
Study
EGAS50000000914
-
Emirati Genome Project subset of 43,608 WGS samples for population-scale variant discovery and allele frequency mapping.
Study
EGAS50000001071
-
Single-Gene vs. Panel Sequencing in Advanced HR+/HER2− Breast Cancer
Study
EGAS00001008200
-
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601
Study
EGAS00001007985
-
McGill Epigenomics Mapping Centre
Study
EGAS00001000995